OPPENHEIMER & CO INC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$229,000
-44.1%
50,000
+5.4%
0.01%
-28.6%
Q1 2022$410,000
-28.2%
47,450
+18.6%
0.01%
-30.0%
Q4 2021$571,000
-25.4%
40,000
+14.9%
0.01%
-28.6%
Q3 2021$765,000
+116.1%
34,800
+31.4%
0.01%
+133.3%
Q2 2021$354,000
+25.5%
26,475
-4.8%
0.01%0.0%
Q1 2021$282,000
+452.9%
27,800
+131.7%
0.01%
+500.0%
Q4 2020$51,00012,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders